Developing an HIV Disclosure Intervention for Men in Uganda
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age18+
SponsorBrigham and Women's Hospital
About this trial
The goal of this clinical trial is to test an HIV disclosure intervention that the investigators are developing focused on men living with HIV in Uganda. The main questions the investigators are trying to answer is whether the HIV disclosure intervention the investigators develop will help men who receive this intervention to disclose their HIV status to a greater extent than men who receive standard care.
Participants assigned to the intervention group will likely participate in the following:
* Sexual health education * Cognitive behavioral therapy strategies * Problem-solving skills building * Motivational interviewing * Developing a personalized HIV disclosure plan * Communication skills building * Role-playing disclosure strategies
Eligibility criteria
Qualifiers
men living with HIV
with sexually transmitted infection symptoms (e.g., urethral discharge, genital lesions)
either not accessing antiretroviral therapy (per self-report109 and/or clinic documentation) or accessing antiretroviral therapy without HIV viral suppression
age ≥18 years,
Disqualifiers
an inability to speak the local language (Runyankole) or English
an inability to provide informed consent
Trial design
Treatments tested in this trial
- HIV disclosure intervention
Treatment groups
70 Participants
are divided into 2 treatment groupsSponsors and collaborators
Brigham and Women's Hospital
Lead sponsor
National Institute of Mental Health (NIMH)
Collaborator
Mbarara University of Science and Technology
Collaborator
Source ClinicalTrials.gov